Antithrombotic strategy in stroke

Thrombosis and Haemostasis

Volumn 86, Issue 1, 2001, Pages 1-7

  Bousser, M G ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Anticoagulants; Antiplatelet drugs; Cerebral infarction; Stroke; Thrombolysis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANCROD; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DALTEPARIN; DIPYRIDAMOLE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; PROUROKINASE; RECOMBINANT PLASMINOGEN ACTIVATOR; STREPTOKINASE; TICLOPIDINE; WARFARIN;

ANTICOAGULANT THERAPY; ARTIFICIAL EMBOLISM; CARDIOVASCULAR RISK; CEREBELLUM HEMORRHAGE; CEREBELLUM INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG CHOICE; DRUG EFFICACY; DRUG MEGADOSE; EMBOLISM; EVIDENCE BASED MEDICINE; HUMAN; LUNG EMBOLISM; PATIENT COMPLIANCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; STROKE; SYMPTOM; THROMBOSIS; TREATMENT OUTCOME; VEIN THROMBOSIS;

ANTICOAGULANTS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC AGENTS; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 0034918223     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (75)

1. Mortality by cause for eight regions of the world: Global burden of disease study
2. A population-based study of dementia in 85 year olds
3. Depression after stroke. Results in the Finn stroke study
4. Acute stroke
5. Stroke treatment. Promising but still struggling
6. Antithrombotic and thrombolytic therapy for ischemic stroke
7. Randomised trial of prophylactic daily aspirin in British male doctors
8. Final report on the aspirin component of the ongoing Physicians' Health Study
9. Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
10. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
11. Aspirin and risk of hemorrhagic stroke: A meta-analysis of randomised controlled trials
12. Low dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice
13. Collaborative overview of randomised trials of antiplatelet therapy
14. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischemia
15. Secondary stroke prevention: A European perspective
16. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: A randomised controlled trial
17. A randomised trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients
18. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
19. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia
20. Prévention des récidives des accidents vasculaires cérébraux ischémiques par les antiagrégants plaquettaires. Résultats d'un essai thérapeutique contrôlé de 3 ans
21. Persantine-aspirin trial in cerebral ischemia: Endpoint results
22. European stroke prevention study 2. Dipyridamole and acetylsalicyclic acid in the secondary prevention of stroke
23. Stroke prevention: Which drugs to use and when?
24. Difficulties with oral platelet glycoprotein IIb/IIIa receptor antagonists
25. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin
26. Antithrombotic therapy in atrial fibrillation
27. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
28. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study
29. Stroke prevention in atrial fibrillation study (SPAF): Final results
30. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
31. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomised trials
32. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
33. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke prevention in atrial fibrillation II study (SPAF II)
34. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
35. Prevention of stroke in patients with non valvular atrial fibrillation
36. Antithrombotic therapy in valvular heart disease
37. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves
38. Stroke prevention. Narrowing the evidence-practice gap
39. Stroke study group. Tissue plasminogen activator for acute ischemic stroke
40. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke
41. Thrombolytic therapy for acute ischemic stroke: Summary statement
42. Thrombolytic therapy in patients with acute ischemic stroke
43. A European view on the North American fifth consensus on antithrombotic therapy
44. CAST: Randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischemic stroke
45. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both or neither among 19435 patients with acute ischaemic stroke
46. Randomised controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischaemic stroke
47. Aspirin, heparin and fibrinolytic therapy in suspected acute myocardial infarction
48. Aspirin or heparin immediately after stroke?
49. A randomized, double blind, placebo-controlled, dose escalation study
50. Potential role of abciximab in ischemic cerebro-vascular disease
51. Low-molecular-weight heparin and heparinoids in acute ischemic stroke. A meta-analysis of randomized controlled trials
52. Low molecular weight heparinoid, ORG 10172 (dapanaroid), and outcome after acute ischemic stroke. A randomized trial
53. Low-molecular-weight heparin versus aspirin in patients with acute ischemic stroke and atrial fibrillation: A double-blind randomised study
54. Effectiveness of heparin treatment for progressing ischaemic stroke: Before and after study
55. Heparin in acute ischaemic stroke. The case for a new clinical trial
56. PROACT-II: Recombinant pro-urokinase (r-ProUK) in acute cerebral thromboembolism: Initial trial results. The PROACT-II investigators
57. Systematic review of evidence on fibrinolytic therapy for acute ischemic stroke
58. Thrombolysis for acute ischemic stroke (Cochrane Review)
59. Fibrinolytic therapy with streptokinase in acute ischemic stroke
60. Streptokinase for acute ischemic stroke with relationship to time of administration
61. European Cooperative Acute Stroke Study (ECASS): Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke
62. Randomized double-blind placebo-controlled trial of fibrinolytic therapy with intravenous alteplase in acute ischemic stroke
63. The Atlantis rt-PA (alteplase) acute stroke trial: Final results
64. Bootstrap statistics of ECASS II data: Just another post hoc analysis of a negative stroke trial?
65. Thrombolysis - The best current option for most patients
66. Thrombolysis - Not a panacea for ischemic stroke
67. Use of tissue-type plasminogen activator for acute ischemic stroke. The Cleveland area experience
68. Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage
69. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection
70. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in acute cerebral thrombo-embolism
71. Controlled trial of Ancrod in ischemic stroke
72. Intravenous Ancrod for treatment of acute ischemic stroke. The STAT study: A randomized controlled trial
73. Ancrod - Is snake venom an antidote for stroke?
74. Cerebral venous thrombosis Nothing, heparin, or local thrombolysis?